10x Genomics, Inc. Cost of Revenue
10x Genomics, Inc. (TXG) reported Cost of Revenue of $38.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-07
- 10x Genomics, Inc. cost of revenue for the quarter ending 2026-06-30 was $38.54M, a 19.41% decline year-over-year.
- 10x Genomics, Inc. cost of revenue for the quarter ending 2026-03-31 was $44.66M, a 9.65% decline year-over-year.
- 10x Genomics, Inc. cost of revenue for the quarter ending 2025-12-31 was $52.98M, a 2.00% decline year-over-year.
- 10x Genomics, Inc. cost of revenue for the quarter ending 2025-09-30 was $48.70M, a 7.59% increase year-over-year.
- 10x Genomics, Inc. cost of revenue for fiscal 2025 was $198.94M, a 1.34% increase from fiscal 2024.
- 10x Genomics, Inc. cost of revenue for fiscal 2024 was $196.30M, a 6.26% decline from fiscal 2023.
- 10x Genomics, Inc. cost of revenue for fiscal 2023 was $209.41M, a 73.95% increase from fiscal 2022.
- 10x Genomics, Inc. cost of revenue for fiscal 2022 was $120.39M, a 62.48% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $38.54M 10-Q · filed 2026-08-07 | $83.20M 10-Q · filed 2026-08-07 | $136.19M derived: sum of 3 quarters · filed 2026-08-07 | $184.88M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $44.66M 10-Q · filed 2026-05-08 | $97.65M derived: sum of 2 quarters · filed 2026-05-08 | $146.34M derived: sum of 3 quarters · filed 2026-05-08 | $194.17M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $52.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $101.68M derived: sum of 2 quarters · filed 2026-02-13 | $149.50M derived: sum of 3 quarters · filed 2026-08-07 | $198.94M 10-K · filed 2026-02-13 |
| 2025-09-30 | $48.70M 10-Q · filed 2025-11-07 | $96.52M derived: sum of 2 quarters · filed 2026-08-07 | $145.96M 10-Q · filed 2025-11-07 | $200.02M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $47.82M 10-Q · filed 2026-08-07 | $97.26M 10-Q · filed 2026-08-07 | $151.33M derived: sum of 3 quarters · filed 2026-08-07 | $196.59M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $49.44M 10-Q · filed 2026-05-08 | $103.50M derived: sum of 2 quarters · filed 2026-05-08 | $148.76M derived: sum of 3 quarters · filed 2026-05-08 | $197.65M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $54.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $99.33M derived: sum of 2 quarters · filed 2026-02-13 | $148.21M derived: sum of 3 quarters · filed 2026-02-13 | $196.30M 10-K · filed 2026-02-13 |
| 2024-09-30 | $45.26M 10-Q · filed 2025-11-07 | $94.14M derived: sum of 2 quarters · filed 2025-11-07 | $142.24M 10-Q · filed 2025-11-07 | $210.43M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $48.88M 10-Q · filed 2025-08-08 | $96.98M 10-Q · filed 2025-08-08 | $165.17M derived: sum of 3 quarters · filed 2026-02-13 | $223.29M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $48.09M 10-Q · filed 2025-05-09 | $116.29M derived: sum of 2 quarters · filed 2026-02-13 | $174.40M derived: sum of 3 quarters · filed 2026-02-13 | $221.61M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $68.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $126.31M derived: sum of 2 quarters · filed 2026-02-13 | $173.52M derived: sum of 3 quarters · filed 2026-02-13 | $209.41M 10-K · filed 2026-02-13 |
| 2023-09-30 | $58.12M 10-Q · filed 2024-10-29 | $105.32M derived: sum of 2 quarters · filed 2024-10-29 | $141.22M 10-Q · filed 2024-10-29 | $178.04M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $47.21M 10-Q · filed 2024-08-08 | $83.10M 10-Q · filed 2024-08-08 | $119.93M derived: sum of 3 quarters · filed 2025-02-13 | $150.31M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $35.90M 10-Q · filed 2024-04-30 | $72.72M derived: sum of 2 quarters · filed 2025-02-13 | $103.10M derived: sum of 3 quarters · filed 2025-02-13 | $130.80M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $36.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $67.20M derived: sum of 2 quarters · filed 2025-02-13 | $94.91M derived: sum of 3 quarters · filed 2025-02-13 | $120.39M 10-K · filed 2025-02-13 |
| 2022-09-30 | $30.38M 10-Q · filed 2023-11-03 | $58.08M derived: sum of 2 quarters · filed 2023-11-03 | $83.56M 10-Q · filed 2023-11-03 | $111.16M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $27.70M 10-Q · filed 2023-08-04 | $53.18M 10-Q · filed 2023-08-04 | $80.78M derived: sum of 3 quarters · filed 2024-02-15 | $105.30M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $25.48M 10-Q · filed 2023-05-04 | $53.08M derived: sum of 2 quarters · filed 2024-02-15 | $77.59M derived: sum of 3 quarters · filed 2024-02-15 | $82.51M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $27.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $52.12M derived: sum of 2 quarters · filed 2024-02-15 | $57.03M derived: sum of 3 quarters · filed 2024-02-15 | $74.09M 10-K · filed 2024-02-15 |
| 2021-09-30 | $24.52M 10-Q · filed 2022-11-03 | $29.43M derived: sum of 2 quarters · filed 2022-11-03 | $46.49M 10-Q · filed 2022-11-03 | $65.39M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $4.92M 10-Q · filed 2022-08-09 | $21.98M 10-Q · filed 2022-08-09 | $40.87M derived: sum of 3 quarters · filed 2023-02-16 | $55.28M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $17.06M 10-Q · filed 2022-05-05 | $35.96M derived: sum of 2 quarters · filed 2023-02-16 | $50.37M derived: sum of 3 quarters · filed 2023-02-16 | $60.42M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $18.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $33.31M derived: sum of 2 quarters · filed 2023-02-16 | $43.36M derived: sum of 3 quarters · filed 2023-02-16 | $58.47M 10-K · filed 2023-02-16 |
| 2020-09-30 | $14.41M 10-Q · filed 2021-11-05 | $24.46M derived: sum of 2 quarters · filed 2021-11-05 | $39.57M 10-Q · filed 2021-11-05 | $56.15M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | $10.05M 10-Q · filed 2021-08-06 | $25.16M 10-Q · filed 2021-08-06 | $41.74M derived: sum of 3 quarters · filed 2022-02-18 | $57.22M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $15.11M 10-Q · filed 2021-05-07 | $31.69M derived: sum of 2 quarters · filed 2022-02-18 | $47.17M derived: sum of 3 quarters · filed 2022-02-18 | $62.18M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | $16.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $32.06M derived: sum of 2 quarters · filed 2022-02-18 | $47.07M derived: sum of 3 quarters · filed 2022-02-18 | $61.03M 10-K · filed 2022-02-18 |
| 2019-09-30 | $15.48M 10-Q · filed 2020-11-12 | $30.49M derived: sum of 2 quarters · filed 2020-11-12 | $44.45M 10-Q · filed 2020-11-12 | $59.35M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $15.01M 10-Q · filed 2020-08-12 | $28.97M 10-Q · filed 2020-08-12 | $43.87M derived: sum of 3 quarters · filed 2021-02-26 | $49.11M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $13.96M 10-Q · filed 2020-05-12 | $28.86M derived: sum of 2 quarters · filed 2021-02-26 | $34.11M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $20.14M derived: sum of 2 quarters · filed 2021-02-26 | $28.66M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $5.24M 10-Q · filed 2019-11-12 | $13.76M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | $10.56M 10-K · filed 2020-02-27 |